Other
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
GE HealthCare Technologies Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation decreased by 943.6% to -$2.23B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 435.3%, from -$416M to -$2.23B.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2022
Last reportedQ1 2026Apr 29, 2026
Metric ID:
other_cash_cash_equivalents_restricted_cash_and_restrict_8b4577Historical Data
11 periods
| Q1 '22 | Q3 '22 | Q1 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$55M | -$26M | $883M | $475M | $59M | -$547M | $1.55B | -$416M | $1.29B | $264M | -$2.23B |
| QoQ Change | — | +52.7% | >999% | -46.2% | -87.6% | <-999% | +384.1% | -126.8% | +409.9% | -79.5% | -943.6% |
| YoY Change | — | — | >999% | >999% | -93.3% | — | +227.2% | -805.1% | +335.6% | -83.0% | -435.3% |
Range-$2.23B – $1.55B
CAGR+339.5%
Avg YoY Growth+347.3%
Median YoY Growth+72.1%
Current Streak2 quarters decline
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation at Other Companies
Frequently Asked Questions
- What is GE HealthCare Technologies's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation?
- GE HealthCare Technologies (GEHC) reported cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation of -$2.23B in Q1 2026.
- How has GE HealthCare Technologies's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation changed year-over-year?
- GE HealthCare Technologies's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation decreased by 435.3% year-over-year, from -$416M to -$2.23B.